INHIBITION OF TOPOISOMERASE-II CATALYTIC ACTIVITY BY PYRIDOACRIDINE ALKALOIDS FROM A CYSTODYTES SP ASCIDIAN - A MECHANISM FOR THE APPARENT INTERCALATOR-INDUCED INHIBITION OF TOPOISOMERASE-II
La. Mcdonald et al., INHIBITION OF TOPOISOMERASE-II CATALYTIC ACTIVITY BY PYRIDOACRIDINE ALKALOIDS FROM A CYSTODYTES SP ASCIDIAN - A MECHANISM FOR THE APPARENT INTERCALATOR-INDUCED INHIBITION OF TOPOISOMERASE-II, Journal of medicinal chemistry, 37(22), 1994, pp. 3819-3827
Several new pyridoacridine alkaloids, dehydrokuanoniamine B (1), sherm
ilamine C (2), and cystodytin J (3), in addition to the known compound
s cystodytin A (4), kuanoniamine D (5), shermilamine B (6), and eilati
n (7), were isolated from a Fijian Cystodytes sp. ascidian. Their stru
ctures were determined by analyses of spectroscopic data. These compou
nds along with a previously reported pyridoacridine, diplamine (8), sh
owed dose-dependent inhibition of proliferation in human colon tumor (
HCT) cells in vitro. All compounds inhibited the topoisomerase (TOPO)
II-mediated decatenation of kinetoplast DNA (kDNA) in a dose-dependent
manner. The pyridoacridines' ability to inhibit TOPO II-mediated deca
tenation of kDNA correlated with their cytotoxic potencies and their a
bility to intercalate into calf thymus DNA. These results suggest that
disruption of the function of TOPO II, subsequent to intercalation, i
s a probable mechanism by which pyridoacridines inhibit the proliferat
ion of HCT cells. Incorporation studies show that pyridoacridines disr
upt DNA and RNA synthesis with little effect on protein synthesis. It
appears that DNA is the primary cellular target of the pyridoacridine
alkaloids. These results are consistent with those for known DNA inter
calators.